Yukio NAKAMURA, Takako SUZUKI, Hideshi YAMAZAKI, & Hiroyuki KATO. (2018). Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis. Archives of Rheumatology, 33(2), 154–159. https://doi.org/10.5606/ArchRheumatol.2018.6366